ALB and diabetic kidney disease: The expression of REG1A has been demonstrated to be significantly increased in blood samples of patients affected by diabetic kidney disease (DKD) [25] and correlated with urinary albumin/creatinine ratio, suggesting a role as a biomarker for the risk of developing DKD.